412 related articles for article (PubMed ID: 26849073)
1. Physiological uptake values of 18F-FDG in long bones of the lower extremity on PET/CT imaging.
van Vliet KE; van Eck-Smit BL; de Jong VM; Goslings JC; Schep NW; Termaat MF
Nucl Med Commun; 2016 Jun; 37(6):589-92. PubMed ID: 26849073
[TBL] [Abstract][Full Text] [Related]
2. Standardized uptake values for [¹⁸F] FDG in normal organ tissues: comparison of whole-body PET/CT and PET/MRI.
Heusch P; Buchbender C; Beiderwellen K; Nensa F; Hartung-Knemeyer V; Lauenstein TC; Bockisch A; Forsting M; Antoch G; Heusner TA
Eur J Radiol; 2013 May; 82(5):870-6. PubMed ID: 23394765
[TBL] [Abstract][Full Text] [Related]
3. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
Shen G; Liang M; Su M; Kuang A
Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
[TBL] [Abstract][Full Text] [Related]
4. Utility of FDG PET/CT in the Characterization of Sinonasal Neoplasms: Analysis of Standardized Uptake Value Parameters.
Ozturk K; Gencturk M; Caicedo-Granados E; Li F; Cayci Z
AJR Am J Roentgenol; 2018 Dec; 211(6):1354-1360. PubMed ID: 30300005
[TBL] [Abstract][Full Text] [Related]
5. Semiquantitative Assessment of
Minamimoto R; Xu G; Jamali M; Holley D; Barkhodari A; Zaharchuk G; Iagaru A
AJR Am J Roentgenol; 2017 Nov; 209(5):1136-1142. PubMed ID: 28777652
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic importance of 18F-FDG PET/CT parameters and total lesion glycolysis in differentiating between benign and malignant adrenal lesions.
Ciftci E; Turgut B; Cakmakcilar A; Erturk SA
Nucl Med Commun; 2017 Sep; 38(9):788-794. PubMed ID: 28692494
[TBL] [Abstract][Full Text] [Related]
7.
Wang Z; Ma D; Yang J
Hell J Nucl Med; 2016; 19(3):241-244. PubMed ID: 27824963
[TBL] [Abstract][Full Text] [Related]
8. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activity in bone metastases of breast and prostate cancer were similar as studied by
Pietrzak A; Czepczynski R; Wierzchoslawska E; Cholewinski W
Hell J Nucl Med; 2017; 20(3):237-240. PubMed ID: 29177262
[TBL] [Abstract][Full Text] [Related]
10. Incidental detection of elastofibroma dorsi on PET-CT: initial findings and changes in tumor size and standardized uptake value on serial scans.
Davidson T; Goshen E; Eshed I; Goldstein J; Chikman B; Ben-Haim S
Nucl Med Commun; 2016 Aug; 37(8):837-42. PubMed ID: 27092663
[TBL] [Abstract][Full Text] [Related]
11. Inusual case of Rosai-Dorfman disease in a
Martin-Marcuartu JJ; Moreno-Caballero M; Nava Mateos JJ; Barquilla Cordero P; Arenas Ore R; Martínez-Esteve A
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(2):108-109. PubMed ID: 32029412
[No Abstract] [Full Text] [Related]
12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
13. Impact of age on FDG uptake in the liver on PET scan.
Lin CY; Ding HJ; Lin CC; Chen CC; Sun SS; Kao CH
Clin Imaging; 2010; 34(5):348-50. PubMed ID: 20813297
[TBL] [Abstract][Full Text] [Related]
14. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
[TBL] [Abstract][Full Text] [Related]
15. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
[TBL] [Abstract][Full Text] [Related]
16. FDG uptake in brown adipose tissue-a brief report on brown fat with FDG uptake mechanisms and quantitative analysis using dual-time-point FDG PET/CT.
Esen Akkas B; Gökaslan D; Güner L; Ilgin Karabacak N
Rev Esp Med Nucl; 2011; 30(1):14-8. PubMed ID: 20702004
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Importance of Bone Marrow Uptake on Baseline
Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
[TBL] [Abstract][Full Text] [Related]
19. FDG-PET/CT for differentiating between aseptic and septic delayed union in the lower extremity.
van Vliet KE; de Jong VM; Termaat MF; Schepers T; van Eck-Smit BLF; Goslings JC; Schep NWL
Arch Orthop Trauma Surg; 2018 Feb; 138(2):189-194. PubMed ID: 28956151
[TBL] [Abstract][Full Text] [Related]
20. Can Spatiotemporal Fluoride (
Lundblad H; Karlsson-Thur C; Maguire GQ; Jonsson C; Noz ME; Zeleznik MP; Weidenhielm L
Clin Orthop Relat Res; 2017 May; 475(5):1486-1498. PubMed ID: 28150226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
